Paula Ferreira

Pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer: Phase III KEYNOTE-181 study.

Takashi Kojima, Kei Muro, Éric François et al. · Journal of Clinical Oncology · 2019 · 207 citations

Advanced Esophageal Cancer, Esophageal Cancer, Gastrointestinal Oncology +11

Hydrops fetalis associated with erythrocyte pyruvate kinase deficiency

Paula Ferreira, Lívia H. Morais, Ricardo J. S. Costa et al. · European Journal of Pediatrics · 2000 · 53 citations

Developmental Biology, Physiology, Fetal Medicine +6

FcγRIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patients

Márcia Paiva, Herlander Marques, Ângelo Martins et al. · Cancer Genetics and Cytogenetics · 2008 · 42 citations

Fcγriia Polymorphism, Lymphoid Neoplasia, Autoimmune Disease +10

Acute Gastric Volvulus and Congenital Posterolateral Diaphragmatic Hernia

Banquart Leitão, Conceição Mota, Carlos Enes et al. · European Journal of Pediatric Surgery · 1997 · 21 citations

Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology

Paula Ferreira, Raquel Catarino, Deolinda Pereira et al. · European Journal of Clinical Pharmacology · 2005 · 13 citations

Cervical Cancer Screening, Cervical Cancer, Cancer Epidemiology +6